Skip to content
CuraVeyra
Explore Clinical DemoLet's talk
Illustrative physician and patient reviewing health information in a bright clinic

CURAVEYRA · CONNECTED HEALTH INTELLIGENCE

Health Changes.We Help YouSee It Coming.

CuraVeyra connects vital signs over time to help care teams recognize meaningful changes. Our developing AI approach aims to identify emerging risk patterns before individual measurements cross configured alert thresholds — supporting earlier human review, from hospital to home.

Explore Clinical Demo Explore the Platform
A clearer view of care
Integration & validation phase

01 / THE HEALTHCARE CHALLENGE

Between Hospital Visits,
Health Doesn't Stand Still.

Patients recover and manage chronic conditions at home. Yet between clinical visits, care teams often have the least visibility — when changes can matter most.

  • 01Limited visibility at home
  • 02Fragmented device data
  • 03Delayed recognition of changing conditions
  • 04Disconnected clinical communication
Illustrative older adult measuring blood pressure with support from her daughter

02 / THE CURAVEYRA APPROACH

From Vital Signs
to Meaningful Action.

Patient

Health begins with the person, not the measurement.

Connected Devices

Vital signs captured where care happens.

Secure Platform

A shared, longitudinal view for authorized teams.

Intelligent Analysis

Rules and trends; AI capabilities under validation.

Clinical Response

Clear alerts and coordinated follow-up.

03 / THE PLATFORM IN ACTION

One Connected View.
A Clearer Next Step.

Patient context, vital trends and care workflows. Together in one clinical workspace.

Illustrative product concept · synthetic data · not for clinical use
CuraVeyra

Heart Failure · Age 71

CV-001 / Patient Overview

Demo status: Elevated Risk
BP

148/92 mmHg

HR

94 bpm

SpO₂

93 %

Weight

84.6 kg

Systolic BP · mmHg7 days
Day 1Day 7
Heart rate · bpm7 days
Day 1Day 7
SpO₂ · %7 days
Day 1Day 7
ECG-style signal · syntheticAdherence 92%
Designed to support — never replace — clinical judgment.Explore Clinical Demo

04 / PREDICTIVE HEALTH INTELLIGENCE

Don't Just Monitor Health.
Anticipate What Comes Next.

Individual vital signs tell part of the story. Their evolution over time can reveal something more. CuraVeyra combines continuous monitoring, trend analysis and developing AI intelligence to identify emerging risk patterns and support timely care decisions.

AI under development & validation

LONGITUDINAL PATIENT VIEW

Small changes. A bigger picture.

Synthetic record
14-day observation
Systolic BP139 mmHg
Resting HR86 bpm
SpO₂95 %
Body weight83.8 kg
Adherence75 %
AI risk trendEmerging
14-day synthetic patient timelineEach row uses its own scale. Measurements through the selected day are observed synthetic data. Dimmed later values are future scenario data, not model predictions.D1D4D7D10D14

Future scenario data · Days 11–14 are dimmed, not model predictions.

Independent scales · AI trend is qualitative, not a probability. Dashed BP line: illustrative 150 mmHg threshold, not a clinical recommendation.

CURAVEYRA INTELLIGENCE LAYERConcept
  1. 01Longitudinal monitoring
  2. 02Combined changes
  3. 03Early warning
  4. 04Human review
D01

Individual baseline

First 7 days of measurements available.

D10

Pattern-based early warning

Combined changes prompt simulated human review.

D14

Conventional threshold

Upcoming in this demo

An individual threshold asks: “Has a limit been crossed?” A pattern-based warning asks: “What is changing together?”

EXPLAINABLE REVIEW · SIMULATED

Synthetic patient CV-AI · First pattern detection: day 10 · Viewing day 10

Emerging Risk Pattern Identified

  • Systolic BP: 128 mmHg on day 1 → 139 mmHg on day 10.

  • Resting HR: 72 bpm on day 1 → 86 bpm on day 10.

  • SpO₂: 98 % on day 1 → 95 % on day 10.

  • Body weight: 82.1 kg on day 1 → 83.8 kg on day 10.

  • Reduced recorded adherence on day 8, day 9, day 10; day 10: 75%.

WHY THIS PATTERN?

The authored example combines the observed blood pressure, heart rate, oxygen saturation, weight and adherence history through day 10. This pattern-based warning is distinct from a single-value threshold alert. Human review is illustrative, not a validated clinical recommendation.

Simulated actions only. No real call, contact or notification is sent.

Today's measurement matters.
Tomorrow's risk may be hidden in the trend.

  1. 01

    Longitudinal Health Monitoring

    A patient’s evolving baseline, not isolated numbers.

  2. 02

    AI-Assisted Pattern Recognition

    An emerging approach to combinations of subtle changes.

  3. 03

    Explainable Early-Warning Alerts

    Observations connected to a responsible human response.

Our approach to responsible AI

Illustrative AI workflow. Predictive models and clinical performance require validation. Not for clinical use.

05 / CARDIOLOGY AND BEYOND

Different Needs.
One Commitment to Care.

Illustrative cardiovascular care scenario

Cardiovascular Care

A more connected view of cardiac health.

Illustrative post-discharge monitoring scenario

Post-Discharge Monitoring

Continuity of care beyond the hospital.

Illustrative chronic disease monitoring scenario

Chronic Disease Monitoring

Recognizing change across everyday measurements.

Illustrative senior & home care scenario

Senior & Home Care

Supporting independence. Staying connected.

06 / ALERTS & COORDINATED RESPONSE

From Measurements to Coordinated Response.

Meaningful changes need a clear next step. CuraVeyra is designed to bring vital-sign trends, available clinical context and explainable alerts into one coordinated workflow — helping designated caregivers and authorized care teams review changes and respond according to configured care protocols.

Explore monitoring & response
  1. 01

    Measurements

  2. 02

    Patient history & context

  3. 03

    Risk assessment

  4. 04

    Explainable alert

  5. 05

    Coordinated response

Recipients selected by severity and configured protocol — not a waiting sequence.

  • Patient / designated caregiver
  • Authorized care team
  • Emergency service integration — plannedNot currently available
Longitudinal trends support earlier recognition of emerging risk. Urgent alerts require a separate, severity-based response pathway.

07 / EVIDENCE & U.S. READINESS

Ambitious About Care.
Transparent About Progress.

Building on the Telemedical remote monitoring foundation, we are preparing device integrations, technical verification and a responsible clinical and regulatory pathway.

CuraVeyra is not FDA-cleared or FDA-approved. Future pilots are subject to agreements, approvals and regulatory requirements.

Read our regulatory roadmap
  1. 01

    Platform Development

    Technology developed
  2. 02

    Device Integration

    In integration / validation
  3. 03

    Technical Verification

    In integration / validation
  4. 04

    Clinical Evaluation Planning

    Planned next step
  5. 05

    FDA Regulatory Pathway Assessment

    Planned next step
  6. 06

    Prospective U.S. Pilot Programs

    Planned next step
Illustrative healthcare professionals discussing a care plan

LET'S BUILD BETTER CARE TOGETHER

The Future of Care Begins Before the Emergency.

Request a Demo Become a Clinical Partner
Investor Inquiry